Co čeká české lázně?

MUDr. Eduard Bláha

Urol. praxi, 2012; 13(4): 143  

Combination drug therapy of the benign prostate hyperplasia

prof.MUDr.Jan Dvořáček, DrSc.

Urol. praxi, 2012; 13(4): 148-153  

Combination drug therapy (CDT) of α-blockers and 5 α-reductase inhibitors is widely used for treatment of lower urinary symptoms in men with benign prostatic hyperplasia, The modes of action these drugs is different and complementary. Both provide sustainable reductions in International Prostate Symptome Score, delay the acute urinary retention and need for invasive BPH therapy. Only the 5-ARIs reduce the long-term risk of acute urinary retention and invasive BPH therapy. MTOPS (Medical Therapy of Prostate Symptoms) study a CombAT (Combination of Avodart and Tamsulosin) trial provided evidence that the prostate volume threshold for...

Densitometry of urological diseases

MUDr.Petr Hrdý, MUDr.Pavel Novosad

Urol. praxi, 2012; 13(4): 154-158  

Densitometry is a radiologic imaging method determined bone mineral density (BMD) and bone mineral content (BMC). Vertebral bodies L1 – L4 in anterioposterior projection and proximal femur in the area of neck (NECK) and globally (TOTAL) is measured according to osteological standards. Diagnosis of osteoporosis is established in accordance with measurement of BMD abnormalities from average values at young healthy individuals, the deviation sets as so-called T-score. Among most frequent causes of osteoporosis in urological ambulance patients belong to hypogonadism and androgen deprived therapy for prostate cancer. There are still basic...

Methods of renal replacement therapy: practical approach in a predialysis patient with chronic kidney disease

MUDr.Ladislava Lyerová, CSc.

Urol. praxi, 2012; 13(4): 159-162  

The number of patients with chronic kidney disease (CKD) has been increasing worldwide. Early diagnosis and treatment are essential for these patients. Efforts to slow the progression of renal insufficiency and delay the need for renal replacement therapy by means of dietary measures, antihypertensive drugs, hypolipidaemic drugs, appropriate choice of medications with dose reduction based on the degree of kidney injury as well as by avoiding nephrotoxic medications or considering contrast examinations should be preferred. The patient should be referred to a nephrology service in time in order to choose an appropriate method of renal replacement...

Noncancer late sequelae treatment for testicular germ cell tumours

MUDr.Tomáš Büchler, Ph.D., MUDr.Jana Grimová, MUDr.Pavla Umhöhová, MUDr.Lucie Žitňanská, prof.MUDr.Jitka Abrahámová, DrSc.

Urol. praxi, 2012; 13(4): 163-166  

The cure rate of testicular germ cell tumours is among the highest of all malignancies. However, therapy for TGN leads to an increased risk of various long-term complications including neurotoxicity, cardiotoxicity, endocrine disturbances, and fertility problems. Awareness, screening and timely therapy for these complications can decrease morbidity and mortality in this population.

Causes and treatment option sexual dysfunction in men

PhDr.Iveta Jonášová, Ph.D.

Urol. praxi, 2012; 13(4): 168-171  

The author in this article tries to provide a brief overview of male sexual dysfunctions and possibilities of their treatment, focusing on psychological perspective of this problem. Ethiopathogenesis is often multifactorial - psychical, biological and constitutional factors take part - even though males psyche is not a main reason of these dysfunctions, it almost constantly influences on evolution of diseases and takes its important part in the tretment.

Radical prostatectomy in patients with preoperative PSA above 20 ng/ml

doc.MUDr.Miloš Broďák, Ph.D., MUDr.Josef Košina, MUDr.Lukáš Holub, MUDr.Pavel Navrátil, CSc., MUDr.Miroslav Louda, Ph.D., MUDr.Jaroslav Pacovský, Ph.D.

Urol. praxi, 2012; 13(4): 173-175  

Radical prostatectomy for patients with PSA > 20 ng/ml preoperatively is linked to worse results including higher carcinoma-specific mortality. Published data from retrospective studies prove high efficiency of the radical prostatectomy in selective cohort of patients. There was evaluated cohort of 22 patients and median follow-up was 62 months. Median PSA was 28 ng/ml. All patients underwent radical prostatectomy, 5 patients experienced of adjuvant radiotherapy and 4 of salvage radiotherapy. No patients died and no distant metastases were recorded.

Primary leiomyosarcoma of the kidney

MUDr.David Jež, MUDr.Roman Staněk, MUDr.Tomáš Kokoř, MUDr.Veronika Kinčeková, MUDr.Josef Palas

Urol. praxi, 2012; 13(4): 177-178  

Leiomyosarcoma of the kidney is a rare malignant tumour. A few hundred cases have been reported in the world literature. Renal sarcomas are less common but have a worse prognosis than sarcomas of other organs of the urogenital tract. Radical nephrectomy is the mainstay of the treatment. The disease tends to disseminate rapidly, and despite agressive treatment, the prognosis of the patients is poor. We present a case history of a 72-year-old patient with a primary leiomyosarcoma of the right kidney at the time when there was no metastatic dissemination. Radical nephrectomy was performed; however, the disease progressed rapidly and the patient...

Cranberries not only in urology

Mgr.Nataša Sochorová, Stanislava Hilšerová, MUDr.Aleš Vidlář, Ph.D.

Urol. praxi, 2012; 13(4): 180-182  

Cranberry has been known for centuries, its original home is North America. It is suitable for use in both salty and sweet dishes, but rather became popular due to its therapeutic effects.

Čistá intermitentní katetrizace

Mgr. Pavla Kordulová, MUDr. Lukáš Bittner, FEBU

Urol. praxi, 2012; 13(4): 186